Myoblast xenotransplantation as a tool to evaluate the appropriateness of nanoparticular versus cellular trackers

Cell Transplantation

Volumn 17, Issue 9, 2008, Pages 1035-1043

  Praud, C ^a,c   Vauchez, K ^a,b   Lombes, A ^a   Fiszman, M Y ^a   Vilquin, J T ^a  

^a INSERM   (France)

^b Genzyrne SA   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

COX2; Ferrites; Human myoblasts; Macrophages; Xenotransplantation

Indexed keywords

CYCLOOXYGENASE 2; FERRITE; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; C57BL 6 MOUSE; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; TIBIALIS ANTERIOR MUSCLE; XENOTRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DENDRIMERS; FERRIC COMPOUNDS; HUMANS; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; MUSCULAR DISEASES; MYOBLASTS; NANOPARTICLES; TIBIA; TRANSPLANTATION, HETEROLOGOUS;

MUS;

EID: 62549140188     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368908786991588     Document Type: Article

References (53)

1. Alameddine, H. S.; Dehaupas, M.; Fardeau, M. Regeneration of skeletal muscle fibers from autologous satellite cells multiplied in vitro. An experimental model for testing cultured cell myogenicity. Muscle Nerve 12(7):544-555; 1989.
2. Arnold, L.; Henry, A.; Poron, F.; Baba-Amer, Y.; van Rooijen, N.; Plonquet, A.; Gherardi, R. K.; Chazaud, B. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204(5): 1057-1069; 2007.
3. Bachrach, E.; Li, S.; Perez, A. L.; Schienda, J.; Liadaki, K.; Volinski, J.; Flint, A.; Chamberlain, J.; Kunkel, L. M. Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells. Proc. Natl. Acad. Sci. USA 101(10):3581-3586; 2004.
4. Baker, R. S.; Bonner, P. H.; Porter, J. D.; Madhat, M. N.; Gross, J. Myoblast transfer therapy in the treatment of ptosis: A preliminary study. J. Pediatr. Ophthalmol. Strabismus 30(2):113-117; 1993.
5. Beauchamp, J. R.; Morgan, J. E.; Pagel, C. N.; Partridge, T. A. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell. Biol. 144(6): 1113-1122; 1999.
6. Borenstein, N.; Hekmati, M.; Bruneval, P.; Montarras, D. Unambiguous identification of implanted cells after cellular cardiomyoplasty: A critical issue. Circulation 109(18): e209-210; 2004.
7. Bouchentouf, M.; Benabdallah, B. F.; Dumont, M.; Rousseau, J.; Jobin, L.; Tremblay, J. P. Real-time imaging of myoblast transplantation using the human sodium iodide symporter. Biotechniques 38(6):937-942; 2005.
8. Bou-Gharios, G.; Wells, D. J.; Lu, Q. L.; Morgan, J. E.; Partridge, T. Differential expression and secretion of alpha 1 anti-trypsin between direct DNA injection and implantation of transfected myoblast. Gene Ther. 6(6):1021-1029; 1999.
9. Brimah, K.; Ehrhardt, J.; Mouly, V.; Butler-Browne, G. S.; Partridge, T. A.; Morgan, J. E. Human muscle precursor cell regeneration in the mouse host is enhanced by growth factors. Hum. Gene Ther. 15(11):1109-1124; 2004.
10. Bulte, J. W.; Douglas, T.; Witwer, B.; Zhang, S. C.; Stable, E.; Lewis, B. K.; Zywicke, H.; Miller, B.; van Geld-eren, P.; Moskowitz, B. M.; Duncan, J. D. Magnetoden-drimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 19(12); 1141-1147; 2001.
11. Cahill, K. S.; Gaidosh, G.; Huard, J.; Silver, X.; Byrne, B. J.; Walter, G. A. Noninvasive monitoring and tracking of muscle stem cell transplants. Transplantation 78(11): 1626-1633; 2004.
12. Cai, B.; Spencer, M. J.; Nakamura, G.; Tseng-Ong, L.; Tidball, J. G. Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors. Am. J. Pathol. 156(5):1789-1796; 2000.
13. Camirand, G.; Caron, N. J.; Asselin, I.; Tremblay, J. P. Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice. Transplantation 72(l):38-44; 2001.
14. Chen, M.; Li, H. J.; Fang, Q.; Goodwin, T. G.; Florendo, J. A.; Law, P. K. Dystrophin cytochemistry in mdx mouse muscles injected with labeled normal myoblasts. Cell Transplant. l(l):17-22; 1992.
15. Cheng, L.; Lai, M. D.; Sanderson, J. E.; Yu, C. M.; Li, M. Enhanced fusion of myoblasts with myofibers for efficient gene delivery induced by a partially purified protein fraction from rat muscle extract. Arch. Biochem. Biophys. 441(2):141-150; 2005.
16. Coulton, G.; Skynner, M.; Pagel, C.; Morgan, J.; Partridge, T. In situ hybridisation of a Y chromosome-specific probe to male myoblasts after implantation into female skeletal muscle. Biochem. Soc. Trans. 19(2): 1958; 1991.
17. Daldrup-Link, H. E.; Rudelius, M.; Oostendorp, R. A.; Settles, M.; Piontek, G.; Metz, S.; Rosenbrock, H.; Keller, U.; Heinzmann, U.; Rummeny, E. J.; Schlegel, J.; Link, T. M. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 228(3):760-767; 2003.
18. Davani, S.; Marandin, A.; Mersin, N.; Royer, B.; Kantelip, B.; Herve, P.; Etievent, J. P.; Kantelip, J. P. Mesenchymal progenitor cells differentiate into an endothelial pheno-type, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 108(Suppl. l):II253-258; 2003.
19. Fan, Y.; Maley, M.; Beilharz, M.; Grounds, M. Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 19(7):853-860; 1996.
20. Fang, Q. W.; Chen, M.; Li, H. J.; Goodwin, T. G.; Law, P. K. Vital marker for muscle nuclei in myoblast transfer. Can. J. Physiol. Pharmacol. 69(l):49-52; 1991.
21. Garot, J.; Unterseeh, T.; Teiger, E.; Champagne, S.; Chazaud, B.; Gherardi, R.; Hittinger, L.; Gueret, P.; Rahmouni, A. Magnetic resonance imaging of targeted catheter-based implantation of myogenic precursor cells into infarcted left ventricular myocardium. J. Am. Coll. Cardiol. 41(10):1841-1846; 2003.
22. Guerette, B.; Asselin, I.; Vilquin, J. T.; Roy, R.; Tremblay, J. P. Lymphocyte infiltration following alio- and xenomyoblast transplantation in mdx mice. Muscle Nerve 18(1):39-51; 1995.
23. Heslop, L.; Beauchamp, J. R.; Tajbakhsh, S.; Buckingham, M. E.; Partridge, T. A.; Zammit, P. S. Transplanted primary neonatal myoblasts can give rise to functional satellite cells as identified using the Myf5nlacZl+ mouse. Gene Ther. 8(10):778-783; 2001.
24. Hodgetts, S. I.; Spencer, M. J.; Grounds, M. D. A role for natural killer cells in the rapid death of cultured donor myoblasts after transplantation. Transplantation 75(6): 863-871; 2003.
25. Huard, J.; Acsadi, G.; Jani, A.; Massie, B.; Karpati, G. Gene transfer into skeletal muscles by isogenic myoblasts. Hum. Gene Ther. 5(8):949-958; 1994.
26. Jockusch, H.; Voigt, S. Migration of adult myogenic precursor cells as revealed by GFP/nLacZ labelling of mouse transplantation chimeras. J. Cell Sci. 116(Pt. 8):1611-1616; 2003.
27. Kinoshita, I.; Huard, J.; Tremblay, J. P. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation. Muscle Nerve 17(9):975-980; 1994.
28. LaBarge, M. A.; Blau, H. M. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 111(4):589-601;2002.
29. Labrecque, C.; Huard, J.; Dansereau, G.; Albert, N.; Tremblay, J. P. In vitro bromodeoxyuridine labeling of nuclei: Application to myotube hybridization. J. Histo-chem. Cytochem. 39(10):1421-1426; 1991.
30. Lafreniere, J. F.; Mills, P.; Tremblay, J. P.; Fahime, E. E. Growth factors improve the in vivo migration of human skeletal myoblasts by modulating their endogenous proteolytic activity. Transplantation 77(11): 1741-1747; 2004.
31. Lee-Pullen, T. F.; Bennett, A. L.; Beilharz, M. W.; Grounds, M. D.; Sammels, L. M. Superior survival and proliferation after transplantation of myoblasts obtained from adult mice compared with neonatal mice. Transplantation 78(8):1172-1176; 2004.
32. Menasche, P.; Hagege, A. A.; Vilquin, J. T.; Desnos, M.; Abergel, E.; Pouzet, B.; Bel, A.; Sarateanu, S.; Scorsin, M.; Schwartz, K.; Bruneval, P.; Benbunan, M.; Marolleau, J. P.; Duboc, D. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 41(7):1078-1083; 2003.
33. Montarras, D.; Morgan, J.; Collins, C.; Relaix, F.; Zaffran, S.; Cumano, A.; Partridge, T.; Buckingham, M. Direct isolation of satellite cells for skeletal muscle regeneration. Science 309(5743):2064-2067; 2005.
34. Pagel, C. N.; Morgan, J. E. Myoblast transfer and gene therapy in muscular dystrophies. Microsc. Res. Tech. 30(6):469-479; 1995.
35. Partridge, T. A.; Grounds, M.; Sloper, J. C. Evidence of fusion between host and donor myoblasts in skeletal muscle grafts. Nature 273(5660):306-308; 1978.
36. Partridge, T. A.; Morgan, J. E.; Coulton, G. R.; Hoffman, E. P.; Kunkel, L. M. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337(6203):176-179; 1989.
37. Peyromaure, M.; Sebe, P.; Praud, C.; DeRocle, G.; Potin, N.; Pinset, C.; Sebille, A. Fate of implanted syngenic muscle precursor cells in striated urethral sphincter of female rats: perspectives for treatment of urinaiy incontinence. Urology 64(5): 1037-1041; 2004.
38. Qu, Z.; Huard, J. Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy. Gene Ther. 7(5):428-437; 2000.
39. Rando, T. A.; Blau, H. M. Primary mouse myoblast purification, characterization, and transplantation for cell- mediated gene therapy. J. Cell Biol. 125(6): 1275-1287: 1994.
40. Salvadori, C.; Peters, I. R.; Day, M. J.; Engvall, E.; Shel-ton, G. D. Muscle regeneration, inflammation, and connective tissue expansion in canine inflammatory myopathy. Muscle Nerve 31(2):192-198; 2005.
41. Sammels, L. M.; Bosio, E.; Fragall, C. T.; Grounds, M. D.; van Rooijen, N.; Beilharz, M. W. Innate inflammatory cells are not responsible for early death of donor myoblasts after myoblast transfer therapy. Transplantation 77(12):1790-1797; 2004.
42. Satoh, A.; Huard, J.; Labrecque, C.; Tremblay, J. P. Use of fluorescent latex microspheres (FLMs) to follow the fate of transplanted myoblasts. J. Histochem. Cytochem. 41(10):1579-1582; 1993.
43. Skuk, D.; Caron, N. J.; Goulet, M.; Roy, B.; Tremblay, J. P. Resetting the problem of cell death following muscle-derived cell transplantation: detection, dynamics and mechanisms. J. Neuropathol. Exp. Neurol. 62(9):951-967: 2003.
44. Skuk, D.; Goulet, M.; Roy, B.; Chapdelaine, P.; Bouchard, J. P.; Roy, R.; Dugre, F. J.; Sylvain, M.; Lachance, J. G.; Deschenes, L.; Senay, H.; Tremblay, J. P. Dystrophin expression in muscles of Duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J. Neuropathol. Exp. Neurol. 65(4):371-386; 2006.
45. Skuk, D.; Goulet, M.; Roy, B.; Piette, V.; Cote, C. H.; Chapdelaine, P.; Hogrel, J. Y.; Paradis, M.; Bouchard, J. P.; Sylvain, M.; Lachance, T. G.; Tremblay, J. P. First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: Eighteen months follow-up. Neuromuscul. Disord. 17(l):38-46; 2007.
46. Smythe, G. M.; Fan, Y.; Grounds, M. D. Enhanced migration and fusion of donor myoblasts in dystrophic and normal host muscle. Muscle Nerve 23(4):560-574; 2000.
47. Strasser, H.; Marksteiner, R.; Margreiter, E.; Pinggera, G. M.; Mitterberger, M.; Frauscher, F.; Ulmer, H.; Fussenegger, M.; Kofler, K.; Bartsch, G. Autologous myoblasts and fibroblasts versus collagen for treatment of stress urinary incontinence in women: a randomised controlled trial. Lancet 369(9580):2179-2186; 2007.
48. Vilquin, J. T.; Guerette, B.; Puymirat, J.; Yaffe, D.; Tome, F. M.; Fardeau, M.; Fiszman, M.; Schwartz, K.; Tremblay, J. P. Myoblast transplantations lead to the expression of the laminin alpha 2 chain in normal and dystrophic (dy/ dy) mouse muscles. Gene Ther. 6(5):792-800; 1999.
49. Vilquin, J. T.; Marolleau, J. P.; Sacconi, S.; Garcin, I.; Lacassagne, M. N.; Robert, I.; Ternaux, B.; Bouazza, B.; Larghero, J.; Desnuelle, C. Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patients. Gene Ther. 12(22):1651- 1662;2005.
50. Walter, G. A.; Cahill, K. S.; Huard, J.; Feng, H.; Douglas, T.; Sweeney, H. L.; Bulte, J. W. Noninvasive monitoring of stem cell transfer for muscle disorders. Magn. Reson. Med. 51(2):273-277; 2004.
51. Watt, D. J.; Partridge, T. A.; Sloper, J. C. Cyclosporin A as a means of preventing rejection of skeletal muscle allografts in mice. Transplantation 31(4):266-271; 1981.
52. Wernig, A.; Zweyer, M.; Irintchev, A. Function of skeletal muscle tissue formed after myoblast transplantation into irradiated mouse muscles. J. Physiol. 522(Pt. 2):333-345; 2000.
53. Yiou, R.; Dreyfus, P.; Chopin, D. K.; Abbou, C. C.; Lefaucheur, J. P. Muscle precursor cell autografting in a murine model of urethral sphincter injury. BJU Int. 89(3): 298-302; 2002.